Navigation Links
Cardium's InnerCool Therapies Unit Announces European Commercialization Agreement for Portfolio of Temperature Modulation Systems
Date:4/1/2008

atment of severe chronic diabetic wounds. TRC's lead product candidate, Excellarate(TM), is a DNA-activated collagen gel for topical treatment formulated with an adenovector delivery carrier encoding human platelet-derived growth factor-BB (PDGF-BB). Excellarate is initially being developed to be administered once or twice for the potential treatment of non-healing diabetic foot ulcers. Other potential applications for TRC's Gene Activated Matrix(TM) (GAM(TM)) technology include therapeutic angiogenesis (cardiovascular ischemia, peripheral arterial disease) and orthopedic products, including hard tissue (bone) and soft tissue (ligament, tendon, cartilage) repair. For more information about Cardium's Tissue Repair Company subsidiary, please visit http://www.t-r-co.com.

Forward-Looking Statements

Except for statements of historical fact, the matters discussed in this press release are forward looking and reflect numerous assumptions and involve a variety of risks and uncertainties, many of which are beyond our control and may cause actual results to differ materially from stated expectations. For example, there can be no assurance that new distribution agreements or other commercialization efforts will effectively accelerate InnerCool's patient temperature modulation business, that product modifications or launches will be successful or that the resulting products will be favorably received in the marketplace, that our products or proposed products will prove to be sufficiently safe and effective, that our products or product candidates will not be unfavorably compared to competitive products that may be regarded as safer, more effective, easier to use or less expensive, that results or trends observed in one clinical study will be reproduced in subsequent studies, that third parties on whom we depend will behave as anticipated, that necessary regulatory approvals will be obtained. Actual results may also
'/>"/>

SOURCE Cardium Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. Teva Pharmaceuticals Altered Peptide Ligand Copaxone Boasts the Greatest Patient Share Among First- and Second-Line Therapies for the Treatment of Multiple Sclerosis
2. Pipeline for Lung Cancer Therapies is Focus of New MedPredict Report
3. Insmed President Interviewed for Follow-On Biologics Podcast: Insmed Inc. President Steve Glover Discusses Safe and Effective Biologic Therapies and Reduced Costs with The American Magazine
4. Quest PharmaTech and BC Cancer Agency to Develop Immuno Photodynamic Therapies for Lung Cancer
5. Fate Therapeutics Created by Leading Stem Cell Scientists to Pursue New Approaches to Stem Cell Therapies
6. Thomson Scientific Publishes Who Is Making The Biggest Splash? - A Quarterly Review of Scientific Literature on Drugs and Therapies From April - June 2007
7. Shire Appoints Sylvie Gregoire President of Human Genetic Therapies Business
8. Intra-Cellular Therapies Provides Overview of its Proprietary Portfolio of Compounds for the Treatment of Female Sexual Dysfunction (FSD)
9. Tengion Announces European Orphan Drug Designation for Neo-Bladder Augment
10. DiObex Announces Presentation of Scientific Poster at Annual Meeting of American Society for Clinical Pharmacology and Therapeutics
11. DaVita Announces Retirement of Former Chief Medical Officer Charles J. McAllister, M.D.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/3/2008)...July 3 /- On June 27, 2008,GeneraMedi...ug,Administration (FDA) for its Epoprostenol for I...rostenol for Injection 1.5 mg is indicated for the...ary hypertension and pulmonary,hypertension associ...YHA,Class III and Class IV patients who do not res...
(Date:7/3/2008)...swire-FirstCall/ -- Advanced Life Sciences,Holding...any engaged in the,discovery, development and comm...eas of infection, cancer and respiratory diseases,...Microcap(R) Index after the,Russell Investment Gro...,global equity indexes on June 27, 2008., (Logo: ...
(Date:7/3/2008)...uly 3 /- Senesco,Technologi...) announced today,that it has contracted with Poly...yplus,s "in vivo-jetPEI" for systemic delivery of ...tor 5A and a plasmid of the Factor,5A gene., Sene...n vivo results,using its combination siRNA and pla...
(Date:7/3/2008)...Xinhua-- Huifeng,Bio-Pharma...B), a leading,developer and producer of plant extr...harmaceutical, nutraceutical and food production i...ion will be made available via,Standard & Poor,s M...service that enables subscribing publicly traded c...
Breaking Biology Technology:GeneraMedix Inc. Receives Approval for Epoprostenol for Injection 1.5 mg 2Advanced Life Sciences Added to Russell Microcap Index 2Advanced Life Sciences Added to Russell Microcap Index 3Senesco Signs a Supply Agreement for Polyplus-transfection's Delivery System 2Senesco Signs a Supply Agreement for Polyplus-transfection's Delivery System 3Senesco Signs a Supply Agreement for Polyplus-transfection's Delivery System 4Huifeng Bio-Pharmaceutical (HFGB) Information to Be Available Through Standard & Poor's Market Access Program 2
...ng to Madison from Chicago is being welcomed with ...rnor Jim Doyle announced earlier this week that C...om the Department of Commerce Technology Venture ...) programs to help the company purchase new equipm...,We are extremely enthusiastic to join the dynamic...
...and communications system. Image courtesy of GE He...ced that his budget will include $10 million for a...ctronic medical record (EMR) systems. , ,"I am com...eive quality health care," Doyle said. "That,s why...at will help to reduce potentially dangerous medic...
... an organization is its information, which is why ...But how much content management does your organiza...ment system (CMS) delivers many benefits to an org...ing deadlines, greater efficiency and a wider rang...rly 1,000 CMS solutions to choose from, identifyin...
...omers in 13 states, 60 percent ownership of Cingul...C was hardly just another local phone company. To ... still a regional operator that lacked overseas pu... before it was announced the company will acquire ..., SBC will simultaneously become the biggest long-...
Other Biology Technology:Doyle proposes $10M to expand use of electronic medical records 2Doyle proposes $10M to expand use of electronic medical records 3Consider the content when managing information online 2Consider the content when managing information online 3Consider the content when managing information online 4SBC and AT&T merger expands global reach for Wisconsin businesses 2SBC and AT&T merger expands global reach for Wisconsin businesses 3
(Date:7/3/2008)...ntibiotics is that, eventually, bacteria outsmart ...ne that confers such resistance, a new drug may be...ty scientists tested the new drug, called Ceftobip...tidrug-resistant Staphylococcus aureus (MRSA) bact... of staphylococcal infections worldwide, both in h...
(Date:7/2/2008)...y, Germany and the U.K. have discovered that our o...to the active ingredient in marijuana (THC), but t...hy skin. This finding on "endocannabinoids" just p...2008 print issue of, The FASEB Journal could lea...from acne to dry skin, and even skin-related tumor...
(Date:7/2/2008)...Wildlife Fund (WWF) is alarmed by the dramatic dec...pulation of Suklaphanta Wildlife Reserve in Nepal,...ities of the endangered species in the Eastern Him...opulation of between 6-14 tigers, down from 20-50 ...a low-key announcement on July 1 based on the resu...
(Date:7/2/2008)...able in German . , Metabolomics aims to determi...r a tissue. The exponents of bioinformatics analyz...al metabolomics study in healthy and diabetic mice...ted with the diabetes drug RoziglitazoneTM. Then, ...rmined in a blood plasma sample of a total of fort...
Breaking Biology News(10 mins):New antibiotic beats superbugs at their own game 2Tigers disappear from Himalayan refuge 2Healthy or diseased? 2Novavax Reports Positive Results from Preclinical Studies of its VLP based Trivalent Seasonal Influenza Vaccine Candidate 1819 1Novavax Reports Positive Results from Preclinical Studies of its VLP based Trivalent Seasonal Influenza Vaccine Candidate 1819 2Novavax Reports Positive Results from Preclinical Studies of its VLP based Trivalent Seasonal Influenza Vaccine Candidate 1819 3Smoking Drinking Cholesterol May Be Alzheimers Risk Factors 16947 1Smoking Drinking Cholesterol May Be Alzheimers Risk Factors 16947 2Smoking Drinking Cholesterol May Be Alzheimers Risk Factors 16947 3Study Shows Pine Bark Naturally Reduces Osteoarthritis 16946 1Study Shows Pine Bark Naturally Reduces Osteoarthritis 16946 2Study Shows Pine Bark Naturally Reduces Osteoarthritis 16946 3Study Shows Pine Bark Naturally Reduces Osteoarthritis 16946 4Study Shows Pine Bark Naturally Reduces Osteoarthritis 16946 5Abbott Announces HUMIRA 28R 29 28adalimumab 29 Approved in Japan for the Treatment of Rheumatoid Arthritis 16943 1Abbott Announces HUMIRA 28R 29 28adalimumab 29 Approved in Japan for the Treatment of Rheumatoid Arthritis 16943 2Abbott Announces HUMIRA 28R 29 28adalimumab 29 Approved in Japan for the Treatment of Rheumatoid Arthritis 16943 3Abbott Announces HUMIRA 28R 29 28adalimumab 29 Approved in Japan for the Treatment of Rheumatoid Arthritis 16943 4Abbott Announces HUMIRA 28R 29 28adalimumab 29 Approved in Japan for the Treatment of Rheumatoid Arthritis 16943 5Abbott Announces HUMIRA 28R 29 28adalimumab 29 Approved in Japan for the Treatment of Rheumatoid Arthritis 16943 6Abbott Announces HUMIRA 28R 29 28adalimumab 29 Approved in Japan for the Treatment of Rheumatoid Arthritis 16943 7
...rogress in understanding the basis of coral reef r...portance of a rare batfish, Platax pinnatus, in pr...reef overgrown with algae. The findings bring to l...h species, which had not been considered a signifi... doing so, the study provides insight into the poo...
...organisms living in water, the force is always aga...ed paramecium, which consistently swims harder goi...Now physicists Karine Guevorkian and James Valles ...gravity on its head and see how the creatures resp...er and live paramecia inside a high-powered electr...
..., air and water pathogens may get a lot easier and...iversity researcher and his team. , Syed Hashsham...l and Environmental Engineering and the Center for...-held device capable of detecting up to 50 microbi...s device will give us the ability to measure patho...
...rom ASM Press uses the familiar genre of the ABC b...rld of microbes. The Invisible ABCs will delight r...and spectacular selection of illustrations. Inten...ue new book will stimulate parents, teachers, libr...scinating world of microorganisms. , "We are immer...
Other Biology News:Fish species plays surprise role in aiding coral reef recovery 2Paramecia adapt their swimming to changing gravitational force 2Professors to develop hand-held pathogen testing device 2
...polyclonal antibody to the Salmonella Common Struc...a serum pool of goats immunized with different str...tive to Salmonella and recognizes all Salmonella s...for Group B and D Salmonella based upon the Kaufma...
Abgene's ALTO-8 is the first automated decapper/capper for Abgene Twist-Lock tubes.
...ilated and BR4i refrigerated multifunction centrif...ed operation at a low sound level with a large ran...ainment. Their AUTO-LOCK rotor exchange system wit...y for use within seconds. Instant rotor exchange...
Sterile, individually wrapped, 4mm Cuvettes
Biology Products: